Approval · Notice of Compliance 5060 · 1995
INTRON A: Notice of Compliance 5060
Issued August 4, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5060
- Date
- August 4, 1995
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication for 3 and 5 million iu/vial: non-hodgkin's lymphoma
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTRON A | Not yet assigned | — |
Medicinal ingredients
- INTERFERON ALFA 2B 1,000,000 UNIT per VIAL
- INTERFERON ALFA 2B 5,000,000 UNIT per VIAL
- INTERFERON ALFA 2B 10,000,000 UNIT per VIAL
- INTERFERON ALFA 2B 5,000,000 UNIT per ML